Pavblu 2 mg (0.05 mL of 40 mg/mL solution) injection Images

Generic Name: aflibercept

This medication has been identified as Pavblu 2 mg (0.05 mL of 40 mg/mL solution) injection. It is supplied by Amgen Inc.

Pavblu is used in the treatment of Macular Degeneration; Macular Edema Following Retinal Vein Occlusion; Diabetic Retinopathy; Macular Edema; Diabetic Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Pavblu 2 mg (0.05 mL of 40 mg/mL solution) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Pavblu

Generic Name

aflibercept

Strength

2 mg (0.05 mL of 40 mg/mL solution) injection

Availability

Prescription only

Drug Class

Anti-angiogenic ophthalmic agents

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Amgen Inc.

National Drug Code (NDC)

multiple

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer